Literature DB >> 32157457

Upregulation of Fucosyltransferase 3, 8 and protein O-Fucosyltransferase 1, 2 genes in esophageal cancer stem-like cells (CSLCs).

Zahra Sadeghzadeh1, Ayyoob Khosravi2,3, Marie Saghaeian Jazi1,2, Jahanbakhsh Asadi4,5.   

Abstract

Recently, studies have shown that Fucosylation plays an important role in the invasion and metastatic process of CSLCs. Understanding the expression pattern of fucosyltransferase (FUT) genes may help to suggest better-targeted therapy strategies for esophageal squamous cell carcinoma (ESCC). The study aimed to address the expression pattern of FUT gene variants in esophageal CSLCs and parental adherent cells. Sphere formation method was used to enrich CSLCs. Expression of FUT genes was examined in tumor sphere and parental adherent cells using the RT-PCR method and then relative expression of detected variants was performed by the Real-Time PCR method in both groups. The detected FUTs, also, were assessed in fresh ESCC tumors and the matched healthy controls. Analysis of The cell surface carbohydrate Lewis x (LeX, CD15) was performed by flow cytometry. Molecular analysis showed that the expression of FUT 3, 8 and POFUT1, 2 genes in tumorsphere were significantly higher than parental adherent cells. Analysis of fresh ESCC tumor tissues and the matched healthy controls showed that FUT8 and POFUT1, 2 genes in contrast to FUT 3 have higher expression in tumor tissues than controls. Flow cytometric analyses revealed that tumorsphere and their parent cells do not differ significantly in Lewis x surface marker. The present study showed that FUT 3, 8 and POFUT1, 2 genes upregulated in esophageal CSLCs in comparison to adherent cells. Understanding the expression pattern of FUT gene variants may help to suggest better-targeted therapy strategies for ESCC.

Entities:  

Keywords:  Cancer stem-like cells (CSLCs); ESCC cancer; Fucosyltransferase genes; Lewis x

Mesh:

Substances:

Year:  2020        PMID: 32157457     DOI: 10.1007/s10719-020-09917-z

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  5 in total

1.  Other Types of Glycosylation.

Authors:  Yohei Tsukamoto; Hideyuki Takeuchi
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

Review 2.  Glycosyltransferases in Cancer: Prognostic Biomarkers of Survival in Patient Cohorts and Impact on Malignancy in Experimental Models.

Authors:  Michela Pucci; Martina Duca; Nadia Malagolini; Fabio Dall'Olio
Journal:  Cancers (Basel)       Date:  2022-04-24       Impact factor: 6.575

Review 3.  FUT8 and Protein Core Fucosylation in Tumours: From Diagnosis to Treatment.

Authors:  Chengcheng Liao; Jiaxing An; Suqin Yi; Zhangxue Tan; Hui Wang; Hao Li; Xiaoyan Guan; Jianguo Liu; Qian Wang
Journal:  J Cancer       Date:  2021-05-13       Impact factor: 4.207

4.  TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2.

Authors:  Ling Zhang; Yingzhen Gao; Xiaojuan Zhang; Min Guo; Jie Yang; Heyang Cui; Pengzhou Kong; Xia Niu; Yanghui Bi; Jing Xu; Ting Yan; Yanchun Ma; Jian Yang; Yu Qian; Fang Wang; Hongyi Li; Feng Liu; Xiaolong Cheng; Yongping Cui
Journal:  Theranostics       Date:  2020-09-14       Impact factor: 11.556

Review 5.  Significant Roles of Notch O-Glycosylation in Cancer.

Authors:  Weiwei Wang; Tetsuya Okajima; Hideyuki Takeuchi
Journal:  Molecules       Date:  2022-03-09       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.